NCT04486742
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- Lurie Children's Hospital Chicago, Illinois, United States
Clinical trial condition
Dermatitis
Explore clinical trials studying Dermatitis. Study availability and eligibility vary by location and protocol.
1,525 public trials
180 recruiting studies
Dermatitis trial results
Completed
HPA Axis Study in Adults
NCT01408511
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
- Locations
-
- PAREXEL Bloemfontein Bloemfontein, South Africa
- PAREXEL George George, South Africa
- PAREXEL Port Elizabeth Port Elizabeth, South Africa
NCT04839380
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +13 more
- Locations
-
- Innovaderm Research Inc. Montreal, Quebec, Canada
- Innovoderm Research Montreal, Quebec, Canada
NCT00488241
- Conditions
- Dermatitis, Eczema, Hand Eczema, +3 more
- Locations
-
- Intendis GmbH Berlin, Germany
NCT06085521
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- Jianzhong Zhang Beijing, China
Completed
A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis
NCT05014438
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
- Locations
-
- Local Institution - 0091 Fremont, California, United States
- Local Institution - 0112 Brandon, Florida, United States
- Local Institution - 0061 Coral Gables, Florida, United States
- Local Institution - 0110 Margate, Florida, United States
NCT06063044
- Conditions
- Asthma, Asthma, Allergic, Atopic Dermatitis, +31 more
- Locations
-
- Second Affiliated Hospital，School of Medicine，Zhejiang University Hangzhou, Zhejiang, China
NCT01949311
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- Regeneron Study Site Anniston, Alabama, United States
- Regeneron Study Site Birmingham, Alabama, United States
- Regeneron Study Site 1 Birmingham, Alabama, United States
- Regeneron Study Site 2 Birmingham, Alabama, United States
Completed
A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)
NCT04626297
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
- Locations
-
- Clinical Research Center of Alabama- Birmingham Birmingham, Alabama, United States
- Burke Pharmaceutical Research Hot Springs, Arkansas, United States
- Arkansas Research Trials North Little Rock, Arkansas, United States
- Orange County Research Institute Anaheim, California, United States
NCT03770858
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- Northwestern University Chicago, Illinois, United States